DOI QR코드

DOI QR Code

Clinical application of genome-wide single nucleotide polymorphism genotyping and karyomapping for preimplantation genetic testing of Charcot-Marie-Tooth disease

  • Kim, Min Jee (Department of Biomedical Sciences, College of Life Sciences, CHA University) ;
  • Park, Sun Ok (Laboratory of Reproductive Genetics, CHA Biotech) ;
  • Hong, Ye Seul (Laboratory of Reproductive Genetics, CHA Biotech) ;
  • Park, Eun A (Department of Biomedical Sciences, College of Life Sciences, CHA University) ;
  • Lee, Yu Bin (Department of Obstetrics and Gynecology, CHA Fertility Center Seoul Station, CHA University School of Medicine) ;
  • Choi, Byung-Ok (Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Kyung-Ah (Department of Biomedical Sciences, College of Life Sciences, CHA University) ;
  • Yu, Eun Jeong (Department of Obstetrics and Gynecology, CHA Fertility Center Seoul Station, CHA University School of Medicine) ;
  • Kang, Inn Soo (Department of Obstetrics and Gynecology, CHA Fertility Center Daegu, CHA University School of Medicine)
  • 투고 : 2021.11.18
  • 심사 : 2022.05.22
  • 발행 : 2022.06.30

초록

Purpose: Preimplantation genetic testing for monogenic disorders (PGT-M) has been successfully used to prevent couples with monogenic disorders from passing them on to their child. Charcot-Marie-Tooth Disease (CMT) is a genetic disorder characterized by progressive extremity muscle degeneration and loss of sensory function. For the first time in Korea, we report our experience of applying single nucleotide polymorphism genotyping and karyomapping for PGT-M of CMT disease. Materials and Methods: Prior to clinical PGT-M, preclinical tests were performed using genotypes of affected families to identify informative single-nucleotide polymorphisms associated with mutant alleles. We performed five cycles of in vitro fertilization PGT-M in four couples with CMT1A, CMT2A, and CMT2S in CHA Fertility Center, Seoul Station. Results: From July 2020 through August 2021, five cycles of PGT-M with karyomapping in four cases with CMT1 and CMT2 were analyzed retrospectively. A total of 17 blastocysts were biopsied and 15 embryos were successfully diagnosed (88.2%). Ten out of 15 embryos were diagnosed as unaffected (66.7%). Five cycles of PGT-M resulted in four transfer cycles, in which four embryos were transferred. Three clinical pregnancies were achieved (75%) and the prenatal diagnosis by amniocentesis for all three women confirmed PGT-M of karyomapping. One woman delivered a healthy baby uneventfully and two pregnancies are currently ongoing. Conclusion: This is the first report in Korea on the application of karyomapping in PGT-M for CMT patients. This study shows that karyomapping is an efficient, reliable and accurate diagnostic method for PGT-M in various types of CMT diseases.

키워드

참고문헌

  1. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974;6:98-118. https://doi.org/10.1111/j.1399-0004.1974.tb00638.x
  2. Patel PI, Lupski JR. Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet 1994;10:128-33. https://doi.org/10.1016/0168-9525(94)90214-3
  3. Berciano J, Sevilla T, Casasnovas C, Sivera R, Vilchez JJ, Infante J, et al. [Guidelines for molecular diagnosis of Charcot-Marie-Tooth disease]. Neurologia 2012;27:169-78. Spanish. https://doi.org/10.1016/j.nrleng.2012.04.006
  4. Bird TD. Charcot-Marie-Tooth hereditary neuropathy overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, eds. GeneReviews®. Seattle (WA): University of Washington, Seattle, 1993-2022.
  5. Braathen GJ. Genetic epidemiology of Charcot-Marie-Tooth disease. Acta Neurol Scand Suppl 2012;193:iv-22.
  6. Hoogendijk JE, Hensels GW, Zorn I, Valentijn L, Janssen EA, de Visser M, et al. The duplication in Charcot-Marie-Tooth disease type 1a spans at least 1100 kb on chromosome 17p11.2. Hum Genet 1991;88:215-8. https://doi.org/10.1007/BF00206075
  7. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-32. https://doi.org/10.1016/0092-8674(91)90613-4
  8. Filadi R, Pendin D, Pizzo P. Mitofusin 2: from functions to disease. Cell Death Dis 2018;9:330. https://doi.org/10.1038/s41419-017-0023-6
  9. Tomaselli PJ, Horga A, Rossor AM, Jaunmuktane Z, Cortese A, Blake JC, et al. IGHMBP2 mutation associated with organ-specific autonomic dysfunction. Neuromuscul Disord 2018;28:1012-5. https://doi.org/10.1016/j.nmd.2018.08.010
  10. Grace J, El-Toukhy T, Scriven P, Ogilvie C, Pickering S, Lashwood A, et al. Three hundred and thirty cycles of preimplantation genetic diagnosis for serious genetic disease: clinical considerations affecting outcome. BJOG 2006;113:1393-401. https://doi.org/10.1111/j.1471-0528.2006.01143.x
  11. Wang CW, Liu YL, Chen CH. Targeting myotonic dystrophy by preimplantation genetic diagnosis-karyomapping. Taiwan J Obstet Gynecol 2019;58:891-4. https://doi.org/10.1016/j.tjog.2019.04.002
  12. Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet 2010;47:651-8. https://doi.org/10.1136/jmg.2009.069971
  13. Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med 2014;16:838-45. https://doi.org/10.1038/gim.2014.45
  14. Gimenez C, Sarasa J, Arjona C, Vilamajo E, Martinez-Pasarell O, Wheeler K, et al. Karyomapping allows preimplantation genetic diagnosis of a de-novo deletion undetectable using conventional PGD technology. Reprod Biomed Online 2015;31:770-5. https://doi.org/10.1016/j.rbmo.2015.08.017
  15. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000;73:1155-8. https://doi.org/10.1016/S0015-0282(00)00518-5
  16. Ben-Nagi J, Wells D, Doye K, Loutradi K, Exeter H, Drew E, et al. Karyomapping: a single centre's experience from application of methodology to ongoing pregnancy and live-birth rates. Reprod Biomed Online 2017;35:264-71. https://doi.org/10.1016/j.rbmo.2017.06.004
  17. Forman EJ, Tao X, Ferry KM, Taylor D, Treff NR, Scott RT Jr. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod 2012;27:1217-22. https://doi.org/10.1093/humrep/des020
  18. Wells D, Delhanty JD. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod 2000;6:1055-62. https://doi.org/10.1093/molehr/6.11.1055